164 related articles for article (PubMed ID: 32437637)
61. [Multicenter study of disease attributes in adult patients with pulmonary hypertension].
Dong L; He JG; Liu ZH; Lu XL; Zeng WJ; Sun YJ; Ni XH; Gu Q; Zhao ZH; Cheng XS; Xiong CM
Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(16):1087-90. PubMed ID: 22781764
[TBL] [Abstract][Full Text] [Related]
62. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.
Mathai SC; Hummers LK; Champion HC; Wigley FM; Zaiman A; Hassoun PM; Girgis RE
Arthritis Rheum; 2009 Feb; 60(2):569-77. PubMed ID: 19180517
[TBL] [Abstract][Full Text] [Related]
63. Association Between Hemodynamic Markers of Pulmonary Hypertension and Outcomes in Heart Failure With Preserved Ejection Fraction.
Vanderpool RR; Saul M; Nouraie M; Gladwin MT; Simon MA
JAMA Cardiol; 2018 Apr; 3(4):298-306. PubMed ID: 29541759
[TBL] [Abstract][Full Text] [Related]
64. [Severe pulmonary involvement in the course of type 1 neurofibromatosis].
Martignac B; Gagnadoux F; Trzepizur W; Beneton N; Vinchon F; Paris A; Montani D; Goupil F
Rev Mal Respir; 2014 Sep; 31(7):621-3. PubMed ID: 25239584
[TBL] [Abstract][Full Text] [Related]
65. Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes.
Ramjug S; Hussain N; Hurdman J; Billings C; Charalampopoulos A; Elliot CA; Kiely DG; Sabroe I; Rajaram S; Swift AJ; Condliffe R
Chest; 2017 Jul; 152(1):92-102. PubMed ID: 28223154
[TBL] [Abstract][Full Text] [Related]
66. [The clinical characteristics of systemic sclerosis-related pulmonary arterial hypertension].
Wang H; Tian Z; Liu Y; Li M; Wang Q; Zeng X; Fang Q
Zhonghua Nei Ke Za Zhi; 2014 May; 53(5):390-3. PubMed ID: 25146407
[TBL] [Abstract][Full Text] [Related]
67. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype.
Pasmant E; Sabbagh A; Hanna N; Masliah-Planchon J; Jolly E; Goussard P; Ballerini P; Cartault F; Barbarot S; Landman-Parker J; Soufir N; Parfait B; Vidaud M; Wolkenstein P; Vidaud D; France RN
J Med Genet; 2009 Jul; 46(7):425-30. PubMed ID: 19366998
[TBL] [Abstract][Full Text] [Related]
68. Association between Rheumatoid Arthritis and Pulmonary Hypertension: Data from the French Pulmonary Hypertension Registry.
Montani D; Henry J; O'Connell C; Jaïs X; Cottin V; Launay D; Habib G; Bourdin A; Jevnikar M; Savale L; Rottat L; Simonneau G; Sitbon O; Humbert M; Allanore Y
Respiration; 2018; 95(4):244-250. PubMed ID: 29490304
[TBL] [Abstract][Full Text] [Related]
69. Isoform-specific NF1 mRNA levels correlate with disease severity in Neurofibromatosis type 1.
Assunto A; Ferrara U; De Luca A; Pivonello C; Lombardo L; Piscitelli A; Tortora C; Pinna V; Daniele P; Pivonello R; Russo MG; Limongelli G; Colao A; Tartaglia M; Strisciuglio P; Melis D
Orphanet J Rare Dis; 2019 Nov; 14(1):261. PubMed ID: 31730495
[TBL] [Abstract][Full Text] [Related]
70. Clinical characteristics, haemodynamics and treatment of pulmonary hypertension in sarcoidosis in a single centre, and meta-analysis of the published data.
Dobarro D; Schreiber BE; Handler C; Beynon H; Denton CP; Coghlan JG
Am J Cardiol; 2013 Jan; 111(2):278-85. PubMed ID: 23290599
[TBL] [Abstract][Full Text] [Related]
71. Lung transplantation for pulmonary vascular disease.
Mendeloff EN; Meyers BF; Sundt TM; Guthrie TJ; Sweet SC; de la Morena M; Shapiro S; Balzer DT; Trulock EP; Lynch JP; Pasque MK; Cooper JD; Huddleston CB; Patterson GA
Ann Thorac Surg; 2002 Jan; 73(1):209-17; discussion 217-9. PubMed ID: 11834012
[TBL] [Abstract][Full Text] [Related]
72. Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension.
Boucly A; Cottin V; Nunes H; Jaïs X; Tazi A; Prévôt G; Reynaud-Gaubert M; Dromer C; Viacroze C; Horeau-Langlard D; Pison C; Bergot E; Traclet J; Weatherald J; Simonneau G; Valeyre D; Montani D; Humbert M; Sitbon O; Savale L
Eur Respir J; 2017 Oct; 50(4):. PubMed ID: 29051269
[TBL] [Abstract][Full Text] [Related]
73. Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.
Hassoun PM; Zamanian RT; Damico R; Lechtzin N; Khair R; Kolb TM; Tedford RJ; Hulme OL; Housten T; Pisanello C; Sato T; Pullins EH; Corona-Villalobos CP; Zimmerman SL; Gashouta MA; Minai OA; Torres F; Girgis RE; Chin K; Mathai SC
Am J Respir Crit Care Med; 2015 Nov; 192(9):1102-10. PubMed ID: 26360334
[TBL] [Abstract][Full Text] [Related]
74. Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study.
Weatherald J; Chaumais MC; Savale L; Jaïs X; Seferian A; Canuet M; Bouvaist H; Magro P; Bergeron A; Guignabert C; Sitbon O; Simonneau G; Humbert M; Montani D
Eur Respir J; 2017 Jul; 50(1):. PubMed ID: 28751413
[TBL] [Abstract][Full Text] [Related]
75. [Investigation of pulmonary hypertension].
Natali D; Simonneau G; Humbert M; Montani D
Rev Pneumol Clin; 2008 Jun; 64(3):151-61. PubMed ID: 18656791
[TBL] [Abstract][Full Text] [Related]
76. NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype.
Pasmant E; Sabbagh A; Spurlock G; Laurendeau I; Grillo E; Hamel MJ; Martin L; Barbarot S; Leheup B; Rodriguez D; Lacombe D; Dollfus H; Pasquier L; Isidor B; Ferkal S; Soulier J; Sanson M; Dieux-Coeslier A; Bièche I; Parfait B; Vidaud M; Wolkenstein P; Upadhyaya M; Vidaud D;
Hum Mutat; 2010 Jun; 31(6):E1506-18. PubMed ID: 20513137
[TBL] [Abstract][Full Text] [Related]
77. Single-lung transplantation for pulmonary hypertension. Three-month hemodynamic follow-up.
Pasque MK; Trulock EP; Kaiser LR; Cooper JD
Circulation; 1991 Dec; 84(6):2275-9. PubMed ID: 1959182
[TBL] [Abstract][Full Text] [Related]
78. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
[TBL] [Abstract][Full Text] [Related]
79. Acute hemodynamic responses to supplemental oxygen and their prognostic implications in pulmonary hypertension.
Leuchte HH; Baezner CJ; Baumgartner RA; Mernitz P; Neurohr C; Behr J
Respiration; 2013; 85(5):400-7. PubMed ID: 23037927
[TBL] [Abstract][Full Text] [Related]
80. Impact of pulmonary hypertension on outcome after single-lung transplantation.
Bando K; Keenan RJ; Paradis IL; Konishi H; Komatsu K; Hardesty RL; Griffith BP
Ann Thorac Surg; 1994 Nov; 58(5):1336-42. PubMed ID: 7979655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
